Long non-coding RNAs in nucleus pulposus cell function and intervertebral disc degeneration.

Area of Science:

• Biomedical Science
• Molecular Biology
• Genetics

Background:

• Intervertebral disc degeneration (IDD) is a primary cause of low back pain, presenting substantial public health and economic challenges.
• The development of IDD is multifactorial, involving genetic, biomechanical, and biochemical elements.
• Dysregulation of nucleus pulposus cells, including altered differentiation, apoptosis, proliferation, and extracellular matrix deposition, is critical in IDD initiation and progression.

Purpose of the Study:

• To review current research on the role of deregulated long non-coding RNAs (lncRNAs) in intervertebral disc degeneration (IDD).
• To explore how specific lncRNAs modulate nucleus pulposus cell functions in the context of IDD.
• To identify potential therapeutic strategies targeting lncRNAs for IDD treatment.

Main Methods:

• Literature review of recent studies on lncRNAs and IDD.
• Analysis of research focusing on specific lncRNAs (e.g., RP11-296A18.3, TUG1, HCG18).
• Examination of the impact of lncRNAs on nucleus pulposus cell behavior and extracellular matrix in IDD.

Main Results:

• Long non-coding RNAs (lncRNAs) are increasingly recognized as significant regulators of gene expression in IDD.
• Deregulated lncRNAs, such as RP11-296A18.3, TUG1, and HCG18, play crucial roles in modulating nucleus pulposus cell functions.
• These lncRNAs influence key cellular processes implicated in IDD pathogenesis.

Conclusions:

• Specific lncRNAs are implicated in the pathogenesis of intervertebral disc degeneration.
• Modulating lncRNAs or their signaling pathways presents a promising avenue for developing novel IDD therapeutics.
• Targeting lncRNAs offers a potential strategy for managing low back pain associated with IDD.